Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Aciphex, Pariet, Rabecid, Razo, Zurcal
Rabeprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production. It belongs to the benzimidazole class of drugs and works by irreversibly blocking the H+/K+-ATPase enzyme system in parietal cells of the gastric mucosa. This action effectively inhibits the final step of gastric acid secretion, providing relief from symptoms related to excess acid.
For treating conditions like heartburn, gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome.
Outcome:
Increased rabeprazole levels
Mechanism:
Inhibition of CYP3A4 metabolism
Outcome:
Potential alteration in INR
Mechanism:
Possible interaction with CYP2C9
Outcome:
Minor increase in rabeprazole levels
Mechanism:
Minor inhibition of CYP2C19
Most likely new formulation: Delayed-release combination with other GI medications (Year 2025, 60% confidence)
Based on current usage trends and emerging competitors, there is a 70% likelihood of generic rabeprazole maintaining market share over the next 5 years.
Proton Pump Inhibitor
Benzimidazole